ALICIA (Acalabrutinib in CLL Therapy)

Active, not recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Lymphocytic Leukemia
Trial Locations (12)

125284

Research Site, Moscow

129110

Research Site, Moscow

198205

Research Site, Saint Petersburg

410028

Research Site, Saratov

450054

Research Site, Ufa

630091

Research Site, Novosibirsk

660022

Research Site, Krasnoyarsk

677008

Research Site, Yakutsk

680009

Research Site, Khabarovsk

Unknown

Research Site, Kaliningrad

Research Site, Syktyvkar

Research Site, Nizhny Novgorod

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY